首页> 外国专利> METHOD OF ADMINISTERING A NEUROSTEROID TO EFFECT ELECTROENCEPHALOGRAPHIC (EEG) BURST SUPPRESSION

METHOD OF ADMINISTERING A NEUROSTEROID TO EFFECT ELECTROENCEPHALOGRAPHIC (EEG) BURST SUPPRESSION

机译:减轻神经甾体影响电描记法(EEG)爆发抑制的方法

摘要

The disclosure provides a method of eliciting electroencephalographic burst suppression or electroencephalographic suppression in a patient. the method includes administering to the patient a formulation comprising neurosteroid nanoparticles having a D50 of less than 2 microns and a polymeric surface stabilizer chosen from hydroxyethyl starch, dextran, and povidone and 0.1 to 50 mg of the neurosteroid per 1 kg of the patient's body weight The neurosteroid may be administered intravenously, intramuscularly, subcutaneously, or orally. Continuous intravenous administration and intravenously, intramuscularly, subcutaneously, or orally administering sequential bolus doses comprising 0.5 mg of ganaxolone per 1 kg of body weight in a human patient, with an interval of less than 30 minutes between two consecutive doses are included in the disclosure.
机译:本公开提供一种在患者中引起脑电图猝发抑制或脑电图抑制的方法。该方法包括向患者施用包含D50小于2微米的神经甾类纳米颗粒和选自羟乙基淀粉,右旋糖酐和聚维酮的聚合物表面稳定剂以及每1千克患者体重0.1至50毫克神经甾类的制剂可以静脉内,肌内,皮下或口服施用神经甾体。在本公开内容中包括连续静脉内施用以及在人类患者中静脉内,肌内,皮下或口服施用每1kg体重包含0.5mg ganaxolone的连续推注剂量,两次连续剂量之间的间隔小于30分钟。

著录项

  • 公开/公告号US2019321375A1

    专利类型

  • 公开/公告日2019-10-24

    原文格式PDF

  • 申请/专利权人 MARINUS PHARMACEUTICALS INC.;

    申请/专利号US201716341598

  • 申请日2017-10-13

  • 分类号A61K31/57;A61K47/32;A61K47/36;A61K9;A61P25/08;A61K9/51;

  • 国家 US

  • 入库时间 2022-08-21 12:11:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号